logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Bulimia Nervosa

    Medications for Bulimia Nervosa

    FiltersReset Filters
    12 results

    • fluoxetine

      (Fluoxetine Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, they also treat depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not approved for Bipolar I or treatment-resistant depression.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      ScieGen Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it is used for depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not suitable for these latter conditions.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      TIME CAP LABORATORIES, INC.
      Usage: Fluoxetine capsules are indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. In combination with Olanzapine, it treats depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monitoring and careful consideration are advised in these clinical applications.

    • fluoxetine

      (Fluoxetine Hydrochloride)
      Vensun Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder (OCD), Bulimia Nervosa, and Panic Disorder. In combination with olanzapine, it treats depressive episodes associated with Bipolar I Disorder. Monotherapy with fluoxetine is not recommended for Bipolar I Disorder.

    • fluoxetine

      (Fluoxetine)
      Cadila Pharmaceuticals Limited
      Usage: Fluoxetine capsules are indicated for treating Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. They can be combined with Olanzapine for Bipolar I Disorder and Treatment Resistant Depression. Monotherapy is not approved for Bipolar I or treatment-resistant cases.

    • fluoxetine

      (Fluoxetine)
      Alembic Pharmaceuticals Limited
      Usage: Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is also used in combination with Olanzapine for treating depressive episodes in Bipolar I Disorder. Monotherapy is not indicated for Bipolar I or treatment-resistant depression.

    • fluoxetine

      (Fluoxetine)
      Aurobindo Pharma Limited
      Usage: Fluoxetine tablets are indicated for the treatment of Major Depressive Disorder in adults and children aged 8-18, Obsessive Compulsive Disorder in ages 7-17, Bulimia Nervosa in adults, and Panic Disorder in adults. Long-term efficacy must be periodically re-evaluated by healthcare providers.

    • fluoxetine hcl

      (Fluoxetine HCl)
      Almatica Pharma LLC
      Usage: Fluoxetine tablets are indicated for treating Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Bulimia Nervosa (binge-eating/vomiting behaviors), and Panic Disorder with or without agoraphobia in both adults and pediatric patients, as supported by clinical trials.

    • fluoxetine hydrochloride

      (Fluoxetine Hydrochloride)
      ANI Pharmaceuticals, Inc.
      Usage: Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. It is not approved for Bipolar I Disorder depressive episodes or treatment-resistant depression.

    • fluoxetine hydrochloride

      (Fluoxetine Hydrochloride)
      Lupin Pharmaceuticals Inc
      Usage: Fluoxetine is indicated for the treatment of Major Depressive Disorder, Obsessive Compulsive Disorder (OCD), Bulimia Nervosa, and Panic Disorder in adults and certain pediatric populations. Its long-term efficacy should be periodically re-evaluated by healthcare providers.